Statement of Ownership (sc 13g)
February 08 2019 - 2:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Solid
Biosciences Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
83422E 105
(CUSIP
Number)
January 25, 2018
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒
Rule 13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
(1)
|
|
NAMES OF
REPORTING PERSONS
Matthew B. Arnold
|
(2)
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)
(a) ☐ (b) ☐
|
(3)
|
|
SEC USE ONLY
|
(4)
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
USA
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
(5)
|
|
SOLE VOTING POWER
3,396,293
|
|
(6)
|
|
SHARED VOTING POWER
-
|
|
(7)
|
|
SOLE DISPOSITIVE POWER
3,396,293
|
|
(8)
|
|
SHARED DISPOSITIVE POWER
-
|
(9)
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,396,293
|
(10)
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
|
(11)
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)
9.6% *
|
(12)
|
|
TYPE OF REPORTING PERSON (SEE
INSTRUCTIONS)
IN
|
(*)
|
Based on 35,432,460 Shares of Issuers Common Stock outstanding as of November 1, 2018, as reported by
Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018 as filed with the Commission on November 13, 2018.
|
Item 1(a).
|
Name of Issuer:
|
Solid Biosciences Inc. (
Issuer
)
Item 1(b).
|
Address of the Issuers Principal Executive Offices:
|
141 Portland St
Cambridge, MA
02139
Item 2(a).
|
Name of Person Filing:
|
Matthew B. Arnold
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
3713 Del Monte Drive
Houston,
Texas 77019
USA
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, $0.001 par value per share
83422E 105
Item 3.
|
If this statement is filed pursuant to Rule
13d-1(b),
or
13d-2(b)
or (c), check whether the person filing is a:
|
Not applicable.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.
|
(a)
|
Amount beneficially owned: 3,396,293 shares of Common Stock.
|
|
(b)
|
9.6%, which is
calculated based on 35,432,460 Shares of Issuers Common Stock outstanding as of
November 1, 2018, as reported by Issuer in its Quarterly Report on Form
10-Q
for the quarterly period ended September 30, 2018 as filed with the Commission on November 13, 2018.
|
|
(c)
|
Number of shares as to which the person has:
|
|
(i)
|
Sole power to vote or direct the vote: 3,396,293
|
|
(ii)
|
Shared power to vote or direct the vote: 0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 3,396,293
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 0
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Not applicable.
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the
Parent Holding Company.
|
Not applicable.
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
Item 9.
|
Notice of Dissolution of Group
|
Not applicable.
Not applicable.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
|
|
|
|
|
|
Date: February 8, 2019
|
|
|
|
By:
|
|
/s/ Matthew B. Arnold
|
|
|
|
|
Name:
|
|
Matthew B. Arnold
|
Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Apr 2023 to Apr 2024